Last updated on March 2018

Uterine Fibroids Study (Premenopausal)


Brief description of study

To assess the safety and efficacy of elagolix 300 mg BID in combination with E2/NETA (estradiol 1.0 mg/norethindrone acetate 0.5 mg QD) compared to placebo at 1 year in reducing heavy menstrual bleeding associated with uterine fibroids in premenopausal women 

Clinical Study Identifier: TX155366

Find a site near you

Start Over

Clinical Trials Management, LLC

3801 Houma Blvd., Suite 200 Metairie, LA USA
  Connect »